Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer

被引：0

作者：

Hideya Onishi ^{[1
]}

Mitsuo Katano ^{[1
]}

机构：

[1] Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan

来源：

World Journal of Gastroenterology | 2014年 / 09期

基金：

日本学术振兴会;

关键词：

Hedgehog signaling pathway; Pancreatic cancer; Cancer stem cells; Hypoxic condition; Therapeutic target;

D O I：

暂无

中图分类号：

R735.9 [胰腺肿瘤];

学科分类号：

100214 ;

摘要：

Pancreatic cancer is one of the most aggressive and difficult cancers to treat.Despite numerous research efforts,limited success has been achieved in the therapeutic management of patients with this disease.In the current review,we focus on one component of morphogenesis signaling,Hedgehog(Hh),with the aim of developing novel,effective therapies for the treatment of pancreatic cancer.Hh signaling contributes to the induction of a malignant phenotype in pancreatic cancer and is responsible for maintaining pancreatic cancer stem cells.In addition,we propose a novel concept linking Hh signaling and tumor hypoxic conditions,and discuss the effects of Hh inhibitors in clinical trials.The Hh signaling pathway may represent a potential therapeutic target for patients with refractory pancreatic cancer.

引用

页码：2335 / 2342

页数：8

共 38 条

[1] Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between
Natalia JURA
Herbert ARCHER
Dafna BAR-SAGI
[J]. Cell Research, 2005, (01) : 72 - 77
[2] Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli[J] . Jin-bin Han,Luming Liu,Li-hua Tang,Wei-dong Shi,Yong-qiang Hua,Jin-jia Chang,Feng Sang.OncoTargets and Therapy . 2013 (defa)
[3] Protein-bound polysaccharide decreases invasiveness and proliferation in pancreatic cancer by inhibition of hedgehog signaling and HIF-1α pathways under hypoxia
Onishi, Hideya
Morisaki, Takafumi
Nakao, Fumihiko
Odate, Seiichi
Morisaki, Takashi
Katano, Mitsuo
[J]. CANCER LETTERS, 2013, 335 (02) : 289 - 298
[4] The Hedgehog inhibitor suppresses the function of monocyte-derived dendritic cells from patients with advanced cancer under hypoxia
Onishi, Hideya
Morisaki, Takashi
Kiyota, Akifumi
Koya, Norihito
Tanaka, Hiroto
Umebayashi, Masayo
Katano, Mitsuo
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 436 (01) : 53 - 59
[5] Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway
Sun, Xiao-Dong
Liu, Xing-E
Huang, Dong-Sheng
[J]. ONCOLOGY REPORTS, 2013, 29 (06) : 2401 - 2407
[6] The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer
Onishi, Hideya
Morisaki, Takashi
Kiyota, Akifumi
Koya, Norihiro
Tanaka, Hiroto
Umebayashi, Masayo
Katano, Mitsuo
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (06) : 1029 - 1039
[7] The dawn of hedgehog inhibitors: Vismodegib[J] . Selvarajan Sandhiya,George Melvin,Srinivasamurthy Kumar,Steven Dkhar.Journal of Pharmacology and Pharmacotherapeutics . 2013 (1)
[8] Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog–GLI pathway[J] . Shih-Hui Li,Junsheng Fu,Dara Nall Watkins,Rakesh K. Srivastava,Sharmila Shankar.Molecular and Cellular Biochemistry . 2013 (1)
[9] Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer
Hwang, Rosa F.
Moore, Todd T.
Hattersley, Maureen Mertens
Scarpitti, Meghan
Yang, Bin
Devereaux, Erik
Ramachandran, Vijaya
Arumugam, Thiruvengadam
Ji, Baoan
Logsdon, Craig D.
Brown, Jeffrey L.
Godin, Robert
[J]. MOLECULAR CANCER RESEARCH, 2012, 10 (09) : 1147 - 1157
[10] Corrigendum to “Triparanol suppresses human tumor growth in vitro and in vivo”[Biochem. Biophys. Res. Commun. 425 (2012) 613–618][J] . Xinyu Bi,Xingpeng Han,Fang Zhang,Miao He,Yi Zhang,Xiu-Yi Zhi,Hong Zhao.Biochemical and Biophysical Research Communications . 2012 (4)

← 1 2 3 4 →